Marchiole et al. [18] used NACT combined with LPL and VRT to preserve fertility in 7 patients with stage IB–IIA1 cervical cancer (tumor size 3.0–4.5 cm; FIGO, 2009). This evidence concerns the gene LPL and cervical cancer.